Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treatment in animal models.

J Guan1, L Bennet, P D Gluckman

  • 1The Liggins Institute, Faculty of Medicine and Health Sciences, The University of Auckland, Auckland, New Zealand.

Endocrine Development
|May 10, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Genetic hearing loss <i>GJB2</i> c.109G>A (p.Val37Ile) consultation key points and clinical significance].

Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery·2026
Same author

[Variant frequency of <i>GJB2</i> c.109G>A (p.Val37Ile) in Chinese patients with hearing loss: a systematic review and Meta-analysis].

Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery·2026
Same author

[Primary prevention study of preimplantation genetic testing for <i>GJB2</i> gene mutation families].

Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery·2026
Same author

[Gender differences in comorbidity characteristics among patients with sudden sensorineural hearing loss].

Zhonghua yi xue za zhi·2026
Same author

Meta-analysis of the effects of age at first calving on production outcomes, calving difficulty, and reproduction in dairy heifers.

Journal of dairy science·2026
Same author

[Analysis of clinical characteristics and factors associated with mortality in hematological patients infected with <i>Stenotrophomonas maltophilia</i>].

Zhonghua yi xue za zhi·2026

Insulin-like Growth Factor 1 (IGF-1) administration protects brain cells after injury. Its effects are enhanced by mild hypothermia, improving neurological function and recovery.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Hypoxic-ischemic injury triggers programmed cell death (apoptosis) in neurons.
  • Insulin-like Growth Factor 1 (IGF-1) is upregulated in brain injury, suggesting a role in recovery.
  • The N-terminal tripeptide of IGF-1, glycine-proline-glutamate (GPE), also shows neuroprotective properties.

Purpose of the Study:

  • To investigate the neuroprotective role of IGF-1 and its derivative GPE after brain injury.
  • To explore factors extending the therapeutic window for IGF-1 treatment.
  • To elucidate the mechanisms underlying IGF-1's neuroprotective effects.

Main Methods:

  • Administration of exogenous IGF-1 and GPE in models of brain injury.
  • Assessment of cell survival in grey and white matter.

Related Experiment Videos

  • Evaluation of long-term neurological function and dopamine neuron survival.
  • Investigation of the role of IGF-1 receptors and binding proteins.

    • Main Results:

    • Exogenous IGF-1 administration protects grey and white matter and improves neurological function.
    • Mild post-hypoxic hypothermia extends the therapeutic window for IGF-1 treatment by delaying apoptosis.
    • GPE administration is neuroprotective and prevents dopamine neuron loss, though it may not mediate IGF-1's direct effects.

    Conclusions:

    • IGF-1 is a potent neuroprotective factor following hypoxic-ischemic brain injury.
    • Therapeutic strategies involving IGF-1, potentially combined with hypothermia, show promise for improving brain recovery.
    • The specific cellular and regional efficacy of IGF-1 highlights the complexity of its neuroprotective mechanisms.